NCT06079216

Brief Summary

Healthcare systems around the world, including within the United States, have long-established shortages of trained caregivers. The American Health Care Association states that "the health care system has experienced a shortage of trained caregivers for critical roles for some time." This scarcity directly impacts the 45,800 Long-Term Care (LTC) communities throughout the U.S. Concurrent with this staff shortage, more than half of LTC residents have some form of dementia. These two issues create a serious public health concern, since dementia is associated with a variety of behavioral expressions, such as aggression, anxiety, and agitation. Behavioral expressions of dementia can be successfully managed with the use of tailored, psychosocial interventions and communication support. Unfortunately, existing staff shortages make the facilitation of such interventions challenging. One powerful and often-overlooked approach to ameliorating staffing shortages involves the utilization of retired volunteers to facilitate interventions for persons with dementia (PWD). Based on the nearly universal love of music and a promising pilot study, the product to be developed and tested in this STTR will build upon the combined prior work of the Principal Investigators. Making Connections Thru Music (MCTM), an urgently needed product, will enable retired volunteers to facilitate an evidence-based music and discussion intervention with PWD. MCTM aims to improve engagement, enhance quality of life, and reduce behavioral expressions in PWD. The intervention will consist of two main components: (1) a comprehensive online training course for volunteers, which will provide a general overview of dementia, demonstrate effective communication strategies to use with PWD, and instruct volunteers to effectively facilitate MCTM sessions, and (2) an app containing a structured MCTM intervention protocol and toolkit, which will be the means by which volunteers facilitate MCTM. MCTM will be marketed to LTC communities.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
196

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 12, 2023

Completed
1.7 years until next milestone

Study Start

First participant enrolled

July 1, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

January 16, 2025

Status Verified

January 1, 2025

Enrollment Period

3 months

First QC Date

October 6, 2023

Last Update Submit

January 15, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Menorah Park Engagement Scale

    The MPES is an observational scale that measures four types of engagement: Constructive Engagement, Passive Engagement, Distracted Engagement, and Non-Engagement / Apathy The MPES also measures Pleasure, defined as clearly observable smiling or laughing. For each item, the minimum possible value is 0 (not at all) and the maximum possible value is 2 (more than half of the time). For Constructive Engagement, Passive Engagement, and Pleasure, higher scores would represent a better outcome. For Distracted Engagement and Non-Engagement, higher scores would represent a worse outcome.

    Baseline (weeks 1-4) Treatment (weeks 5-12)

Secondary Outcomes (3)

  • Alzheimer's Disease Knowledge Scale

    Baseline (weeks 1-4) Treatment (weeks 5-12)

  • Geriatric Depression Scale- Short Form. Scores can range from zero to 15. Higher scores suggest a worse outcome

    Baseline (weeks 1-4) Treatment (weeks 5-12)

  • Neuropsychiatric Inventory - Nursing Home.

    Baseline (weeks 1-4) Treatment (weeks 5-12)

Study Arms (2)

MCTM Intervention

EXPERIMENTAL

Activity sessions will be led by activity volunteers

Behavioral: Volunteer Led Making Connections Thru Music

Control

ACTIVE COMPARATOR

Activity sessions will be led by activity professionals

Behavioral: Staff Led Making Connections Thru Music

Interventions

Volunteer led Group music therapy-based intervention

MCTM Intervention

Staff led Group music therapy-based intervention

Control

Eligibility Criteria

Age18 Years - 103 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Volunteers must be aged 55+ and speak/read conversational English.
  • Staff participants must be at least 18 years old, work within a residential care facility participating in the study, and speak and read English.

You may not qualify if:

  • Volunteers will be excluded if they are diagnosed with dementia based on self-report and/or if they score 23 or lower on theMini Mental State Exam (MMSE; Folstein et al., 1975). Such a score would be indicative of possible cognitive impairment.
  • Staff members will be excluded if they work third shift only. PWD Residents with dementia must be diagnosed with dementia (any type), score 10 or above on the MMSE, be aged 65+, and speak/read conversational English.
  • PWD will be excluded if they show signs of rapid physical or cognitive decline (based upon staff report or as evidenced by information gained during screening).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Hearthstone Institute, LLC

Winchester, Massachusetts, 01890, United States

Location

MeSH Terms

Conditions

DementiaAlzheimer DiseaseDementia, Vascular

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersTauopathiesNeurodegenerative DiseasesCerebrovascular DisordersIntracranial ArteriosclerosisIntracranial Arterial DiseasesLeukoencephalopathiesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Director of Research

Study Record Dates

First Submitted

October 6, 2023

First Posted

October 12, 2023

Study Start

July 1, 2025

Primary Completion

September 30, 2025

Study Completion

September 30, 2025

Last Updated

January 16, 2025

Record last verified: 2025-01

Locations